https://www.selleckchem.com/pr....oducts/salubrinal.ht
001), visually locating a place setting on a dining table (p0.001) and visually locating people in a non-crowded setting (p0.001). Visual function was improved on most standardized tests. Only two device- or procedure-related serious adverse events were observed (one vitreous haemorrhage and one endophthalmitis, both resolved with treatment). No explantation was required. This first report of a completed post-approval study of Argus II with a two-year follow-up demonstrates the safety and effectiveness of the Argus II System
Like
Comment
Share
